These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 21159882)
1. Antiviral activity of human immunodeficiency virus type 1 Gag-specific cytotoxic T lymphocyte targeting is not necessarily intrinsically superior to envelope targeting. Chen DY; Balamurugan A; Ng HL; Yang OO J Virol; 2011 Mar; 85(5):2474-8. PubMed ID: 21159882 [TBL] [Abstract][Full Text] [Related]
2. The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope. Kan-Mitchell J; Bisikirska B; Wong-Staal F; Schaubert KL; Bajcz M; Bereta M J Immunol; 2004 May; 172(9):5249-61. PubMed ID: 15100263 [TBL] [Abstract][Full Text] [Related]
3. HIV-1 gag cytotoxic T lymphocyte epitopes vary in presentation kinetics relative to HLA class I downregulation. Balamurugan A; Ali A; Boucau J; Le Gall S; Ng HL; Yang OO J Virol; 2013 Aug; 87(15):8726-34. PubMed ID: 23740989 [TBL] [Abstract][Full Text] [Related]
4. Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia. Yang OO; Daar ES; Ng HL; Shih R; Jamieson BD AIDS Res Hum Retroviruses; 2011 Apr; 27(4):391-8. PubMed ID: 21087140 [TBL] [Abstract][Full Text] [Related]
6. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection. Pettersen FO; Taskén K; Kvale D Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 evolution in gag and env is highly correlated but exhibits different relationships with viral load and the immune response. Piantadosi A; Chohan B; Panteleeff D; Baeten JM; Mandaliya K; Ndinya-Achola JO; Overbaugh J AIDS; 2009 Mar; 23(5):579-87. PubMed ID: 19516110 [TBL] [Abstract][Full Text] [Related]
8. Cross-reactions between the cytotoxic T-lymphocyte responses of human immunodeficiency virus-infected African and European patients. Durali D; Morvan J; Letourneur F; Schmitt D; Guegan N; Dalod M; Saragosti S; Sicard D; Levy JP; Gomard E J Virol; 1998 May; 72(5):3547-53. PubMed ID: 9557634 [TBL] [Abstract][Full Text] [Related]
9. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. Kan-Mitchell J; Bajcz M; Schaubert KL; Price DA; Brenchley JM; Asher TE; Douek DC; Ng HL; Yang OO; Rinaldo CR; Benito JM; Bisikirska B; Hegde R; Marincola FM; Boggiano C; Wilson D; Abrams J; Blondelle SE; Wilson DB J Immunol; 2006 Jun; 176(11):6690-701. PubMed ID: 16709828 [TBL] [Abstract][Full Text] [Related]
10. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences. Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335 [TBL] [Abstract][Full Text] [Related]
11. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287 [TBL] [Abstract][Full Text] [Related]
12. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. Goulder PJ; Altfeld MA; Rosenberg ES; Nguyen T; Tang Y; Eldridge RL; Addo MM; He S; Mukherjee JS; Phillips MN; Bunce M; Kalams SA; Sekaly RP; Walker BD; Brander C J Exp Med; 2001 Jan; 193(2):181-94. PubMed ID: 11148222 [TBL] [Abstract][Full Text] [Related]
14. Epitope targeting and viral inoculum are determinants of Nef-mediated immune evasion of HIV-1 from cytotoxic T lymphocytes. Chen DY; Balamurugan A; Ng HL; Cumberland WG; Yang OO Blood; 2012 Jul; 120(1):100-11. PubMed ID: 22613796 [TBL] [Abstract][Full Text] [Related]
15. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses. Salgado M; Garcia-Minambres A; Dalmau J; Jiménez-Moyano E; Viciana P; Alejos B; Clotet B; Prado JG; Martinez-Picado J J Virol; 2018 Jun; 92(12):. PubMed ID: 29593044 [TBL] [Abstract][Full Text] [Related]
16. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins. Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377 [TBL] [Abstract][Full Text] [Related]
17. Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges. Khattar SK; Manoharan V; Bhattarai B; LaBranche CC; Montefiori DC; Samal SK mBio; 2015 Jul; 6(4):e01005. PubMed ID: 26199332 [TBL] [Abstract][Full Text] [Related]
19. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals. Schmitt-Haendle M; Bachmann O; Harrer E; Schmidt B; Bäuerle M; Harrer T Viral Immunol; 2005; 18(4):627-36. PubMed ID: 16359229 [TBL] [Abstract][Full Text] [Related]
20. Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy. Prebensen C; Lind A; Dyrhol-Riise AM; Kvale D PLoS One; 2016; 11(4):e0153849. PubMed ID: 27128502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]